10/18/2024

Janusmed sex and gender

Janusmed sex and gender – calcipotriol hydrate

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Calcitriol / Calcipotriene

Calcitriol / Calcipotriene

Class : B

  1. Schwartz JB. The influence of sex on pharmacokinetics. Clin Pharmacokinet. 2003;42:107-21.
  2. Karakawa M, Komine M, Takekoshi T, Sakurai N, Minatani Y, Tada Y et al. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris. J Dermatol. 2011;38:655-60.
  3. Stefanaki C, Lagogianni E, Kontochristopoulos G, Verra P, Barkas G, Katsambas A et al. Psoriasis in children: a retrospective analysis. J Eur Acad Dermatol Venereol. 2011;25:417-21.
  4. Pearce DJ, Camacho F, Balkrishnan R, Fleischer AB, Feldman SR. Trends in on and off-label calcipotriene use. J Dermatolog Treat. 2006;17:308-13.
  5. Ständer S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol. 2013;168:1273-80.
  6. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2016 [cited 2017-05-20.]